Sign in

CIK 0001906324

  • Large accelerated filer

QuidelOrtho Corp

Sign in to watch
Ticker
QDEL
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Jan 1
Entity type
Operating
EIN
874496285
Phone
+1 858-552-1100
Business address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
Former names
Coronado Topco, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-28 Busky Joseph M Chief Financial Officer Grant or award · Restricted Stock Units +14,775 14,775
2023-03-28 Bujarski Robert Joseph EVP & COO Grant or award · Non-Qualified Stock Option +14,775 14,775
2023-03-28 Bujarski Robert Joseph EVP & COO Grant or award · Restricted Stock Units +14,775 14,775
2023-03-28 BRYANT DOUGLAS C President & CEO Grant or award · Non-Qualified Stock Option +31,027 31,027
2023-03-28 BRYANT DOUGLAS C President & CEO Grant or award · Restricted Stock Units +31,028 31,028
2023-02-28 BRYANT DOUGLAS C President & CEO Grant or award · Restricted Stock Units (Converted) +10,656 10,656
2023-02-28 BRYANT DOUGLAS C President & CEO Grant or award · Restricted Stock Units (Premium) +3,273 3,273
2023-02-23 BRYANT DOUGLAS C President & CEO Grant or award +15,180 542,070
2023-02-23 BRYANT DOUGLAS C President & CEO Shares withheld for taxes −7,527 $88.71 $668K 534,543
2023-02-17 BUECHLER KENNETH F Director Exercise or conversion +8,081 $23.70 $192K 78,369
2023-02-17 BUECHLER KENNETH F Director Sale −8,081 $90.26 $729K 70,288
2023-02-17 BUECHLER KENNETH F Director Exercise or conversion · Non-Qualified Stock Options −8,081 0
2023-02-11 Kroll Werner SVP, Research & Development Grant or award +2,743 29,137
2023-02-11 Kroll Werner SVP, Research & Development Shares withheld for taxes −1,296 $86.50 $112K 27,841
2023-02-11 Kroll Werner SVP, Research & Development Grant or award +823 28,664
2023-02-11 Kroll Werner SVP, Research & Development Shares withheld for taxes −409 $86.50 $35K 28,255
2023-02-11 Kroll Werner SVP, Research & Development Exercise or conversion · Restricted Stock Units (Converted) −2,743 0
2023-02-11 Kroll Werner SVP, Research & Development Exercise or conversion · Restricted Stock Units (Premium) −823 0
2023-02-11 Bujarski Robert Joseph EVP & COO Grant or award +2,749 37,103
2023-02-11 Bujarski Robert Joseph EVP & COO Shares withheld for taxes −1,381 $86.50 $119K 35,722

Page 37 of 50 · 990 trades